Loading...
HomeMy WebLinkAbout082323 Sleep can be a cancer patient's best elixirCancer and sleep issues | RNA stability and prostate cancer | Cancer and LGBTQ+ community ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ View as Web page <https://secure.fredhutch.org/site/R?i=0yqVTCnJ-ru7CMK6iwlAeMxS70A2J-FnazFd63vIz454bcjQD2wUTg> <https://secure.fredhutch.org/site/R?i=R5X0bGcRpHTWmx4swaLU8ApS-ksxMPILXoa90YneDno5CVbByBE-ww> <https://secure.fredhutch.org/images/content/pagebuilder/fhcc-eml-hdr-shadow.png> <https://secure.fredhutch.org/images/content/pagebuilder/hdr-eml-hutch-news-fhcc.jpg> August 23, 2023 ⋅ A monthly digest of the latest from Fred Hutch Treatments, stress can be challenges to getting consistent, quality sleep <https://secure.fredhutch.org/site/R?i=6geC1xH6Tp-6I-zusy-Todw3szWbm-JUddfvzgsP-dJE8K2u1iyy9Q> Everyone diagnosed with cancer has access to a powerful tool that can help them stay strong and remain calm, all while encouraging their body’s immune system to seek out and destroy every cancer cells it finds. The problem is many patients are completely unaware of the benefits of this therapy or, for reasons unknown, can’t get enough of it. What is this amazing elixir? Sleep. “We have devalued sleep for so long,” said Fred Hutchinson Cancer Center epidemiologist Amanda Phipps, PhD, MPH, who studies how lifestyle factors impact cancer risk and outcomes. “Sleep is viewed almost as a luxury but in reality, it’s an essential human function. And there are clinical and biological consequences for patients with cancer who are not getting as much sleep as their bodies’ need.” Sleep is so valuable to cancer patients that the National Comprehensive Cancer Network just updated their survivorship guidelines to include new recommendations for clinicians to check in with patients about their sleep. Research shows a full third of cancer survivors experience long-term sleep disturbances, yet very few are evaluated for sleep disorders. So, how are you sleeping <https://secure.fredhutch.org/site/R? i=pQu-JmXIL1VQR_4Ci0F0WlCJhAOizv4PAAaOTTw06eMnRZ4q3HwPhA> ? ________________________________ Events and Seminars <https://secure.fredhutch.org/site/R?i=kO7SSbfVGlfDbond4f_eAwbIDmqqlSCQKBMM3fwm5DTjYi6ix3ZPQw> Pictured above: BACPAC event chair Yaw A. Nyame, MD, gives a presentation at the Seattle Translational Tumor Research retreat in June. Photo by Robert Hood / Fred Hutch News Service Fred Hutchinson Cancer Center and the University of Washington Medical Center in collaboration with the Black and African-descent Collaborative for Prostate Cancer Action (BACPAC) invite you to the free, education event, BACPAC Prostate Cancer Community Research Symposium <https://secure.fredhutch.org/site/R?i=6dNX66RS2WZqqMc9INv_AklmhAoJNCUGa4DUjbEJaQIaJblZ3fp90Q> . This event aims to bring together community members, advocates, researchers and clinicians in a forum expressly designed to meet the needs of the Black community for education and action around prostate cancer equity. Register Now <https://secure.fredhutch.org/site/R?i=CatJ7P2s1kO11jbiNbYMK7T-hLjNJOI246MhcjaZLCfMNt2oxhMYkQ> ________________________________ The Latest RNA stability may play a role in prostate cancer <https://secure.fredhutch.org/site/R?i=WK1ghxoxmzDyEpbGyD9JCKAMtWeCmoB7mSDJCHOa5y8-YE7pzit2CA> Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work led by Fred Hutch scientists Andrew Hsieh, MD, and Samantha Schuster, PhD. Focusing on prostate cancer treatment without surgery <https://secure.fredhutch.org/site/R?i=---LvSHh2fJwy1DqAdcy1-lnGkL5KBF-eG803s4DxJrZgKLzK7wX3Q> A prostate cancer patient chose HIFU, high-intensity focused ultrasound, a noninvasive, targeted treatment at Fred Hutch because surgery was out of the question due to his autoimmune disorder that destroyed blood-clotting platelets. Cancer and the LGBTQ+ community <https://secure.fredhutch.org/site/R?i=PO2fvKySXIbPO0y7brVWViVTKu2bUxIGoTDUPBuasSo8vAD0ttivZg> From delayed diagnoses to missing choices on medical forms to simply not being seen, heard, acknowledged or offered much-needed preventive screening — the LGBTQ+ cancer patients experience can be frustrating, heartbreaking and at times, much harder than necessary. Identifying an experimental diagnostic to personalize ovarian cancer treatment <https://secure.fredhutch.org/site/R?i=i--ys8HlbjQocgC_TZ_wL83KyTB4PkjUsAgjBPzsFQY5zftzMELNAQ> Precision oncology research is typically about finding ways to match patients with a treatment tailored to their tumors. But in new work published by a Fred Hutch research team instead developed a potential diagnostic that can identify patients with high-grade serous ovarian cancer who won’t benefit from standard treatment. Comprehensive Hematology & Oncology Review Course <https://secure.fredhutch.org/site/R?i=zv29MRiSiglLwATyXeOHyPU2dsFBcSkq7vnHCvY0yD3qGSLWZdFaog> Join experts from Fred Hutch for this accredited symposium intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders. The program will cover data supporting guidelines, recommendations and recent advances regarding therapeutic options for their patients. ________________________________ Good News Aaron Ring receives Anderson Family Endowed Chair for Immunotherapy <https://secure.fredhutch.org/site/R?i=B0Rm8Fyt8y2-Crv0lbCe40-FStJ1HVqHRjWKPBIDo3g_qvzAJDguvg> Fred Hutch bioengineer Aaron Ring, MD, PhD, was recently named the new Anderson Family Endowed Chair for Immunotherapy. Endowed by Ric and Kaylene Anderson, the chair will provide him with sustained support as he untangles the immune system’s complexities and uses immuno-pharmacological approaches to develop cancer immunotherapies. Hans-Peter Kiem awarded amfAR grant <https://secure.fredhutch.org/site/R?i=0pfIBzygba9xBYoEU1HWc8NK6ZA8vQyyXwTf2eo0hKWDGyXLgycvOg> The most meaningful HIV cure will be not only safe and effective but also widely accessible for the 39 million people infected worldwide. Fred Hutch’s Hans-Peter Kiem, MD, PhD, is pursuing in vivo gene therapy that confers HIV resistance to a specific subset of a patient’s hematopoietic stem cells and was awarded $480,000 by amfAR, The Foundation for AIDS Research, to support the next stage of his work. Akhila Rajan receives McKnight Award <https://secure.fredhutch.org/site/R?i=y9G1R8BqJ_aMIVQKxuzcQyq5yDIt_nzolAeqLRGQm1tINb1afgKKcg> The health of our fat cells may influence the health of other organs and Fred Hutch obesity researcher Akhila Rajan, PhD, has received a McKnight Foundation award to map that link. Grant King named a 2023 Damon Runyon Fellow <https://secure.fredhutch.org/site/R?i=KP63YPqo1bjx-x_GuYlDisTJN9Op48ZL8aZKUku5ZZg8zjBbCFmO_A> Fred Hutch’s Grant King, PhD, was named a 2023 Postdoctoral Fellow by the Damon Runyon Cancer Research Foundation. The four-year, $300,000 award will allow King to study how “extra-chromosomal” DNA, or DNA that breaks away from larger chromosomes, can persist long-term in cells. Thousands join Obliteride to help cure cancer faster <https://secure.fredhutch.org/site/R?i=e9DfM3hXF1tzLxfCBwRvfYKVF2WdPmOm9fMl5j0buQmnZJogC8GZAw> Cheers, sun and big hearts came together on August 11 and 12, as a community of more than 4,300 participants and volunteers gathered for Obliteride, Fred Hutch’s annual summer bike ride, 5K walk/run and fundraiser. Thousands celebrating in-person in Seattle, Washington, were joined by virtual participants around the world. ________________________________ Base 2 Space Is October 1 Don’t miss this unforgettable opportunity to climb the 832 open-air stairs of the Seattle Space Needle while fundraising for Fred Hutch. <https://secure.fredhutch.org/site/R?i=FMvEjhB-_f4SkQYJ9JLEo9K_Hc_CU0O5KCH_jSLGLOXvbKTT1qIa4w> ________________________________ Share this newsletter with family or friends <https://secure.fredhutch.org/site/R?i=Dzu4MXE0t4KfhozrVVBN00ENTcpPCmeMdshIWv9dmu-NcFtOfP_kUQ> <https://secure.fredhutch.org/site/R?i=SIHmP-Ex8b7mwY-ydziobbdY53Vk1BRvpB55QCieFNzJzrci4apRsg> 1100 Fairview Ave. N., Seattle, WA 98109 communications@fredhutch.org <mailto:communications@fredhutch.org> 206.667.5000 <https://secure.fredhutch.org/site/R?i=1bWWaWTyG6gQlsAgMh5zev8YLZZkAKdNrUdQ_hKwC6ul3i7mtSIPkQ> <https://secure.fredhutch.org/site/R?i=62Ume6mU5C5XuyhWfsddIvAgjm8LUGs0SNqs_oIFAI80xFyzVkqUig> <https://secure.fredhutch.org/site/R?i=O0pkzNqAfcMCpKQYuq3FwTvDE2NTggjl2vDvoOaHnscjXHA-sh63HA> <https://secure.fredhutch.org/site/R?i=CY_J3bG8xX0EobahU6qM8PbnXBogOU8MppSlYDt1M6uDcA3GqXWMAw> ________________________________ Fred Hutchinson Cancer Center is a 501(c)(3) nonprofit organization. You can adjust your email preferences <http://engage.fredhutch.org/site/CO?i=MCqpZkaTBRg1gnBufVrBPW_-jNMr-ZhiTvPOxw5l8168IOxZMXqq91YKaMKz8j0o&cid=1021> at any time or contact us at optout@fredhutch.org <mailto:optout@fredhutch.org> to be removed from both mail and email lists. For information about our privacy practices, see our Privacy Policy <https://secure.fredhutch.org/site/R?i=RrE_NeLykTjGL-fTj28YLKCoCdqKtc3ALt5Kul99FEHsYePVBoRBsw> . © 2023 Fred Hutchinson Cancer Center. All rights reserved. <http://engage.fredhutch.org/site/PixelServer?j=y0kbiN6SkmPaVhFi9peOMHqfscXYzAgWsquC5-BBsyEMVQi1WvAPew> onId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=47c9bed2-cba2-4b0a-9827-1628583e0e1f", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=i--ys8HlbjQocgC_TZ_wL83KyTB4PkjUsAgjBPzsFQY5zftzMELNAQ", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "8cafb54a-b321-40d1-b584-8497e7356fa9", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=8cafb54a-b321-40d1-b584-8497e7356fa9", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=zv29MRiSiglLwATyXeOHyPU2dsFBcSkq7vnHCvY0yD3qGSLWZdFaog", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "ae59e360-a0e3-4104-9f15-e8477da71291", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=ae59e360-a0e3-4104-9f15-e8477da71291", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=B0Rm8Fyt8y2-Crv0lbCe40-FStJ1HVqHRjWKPBIDo3g_qvzAJDguvg", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "2fdddeb9-747c-4fc7-86f6-6ea3902bec9a", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=2fdddeb9-747c-4fc7-86f6-6ea3902bec9a", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=0pfIBzygba9xBYoEU1HWc8NK6ZA8vQyyXwTf2eo0hKWDGyXLgycvOg", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "57ebecf9-322b-4783-840d-96ad868348f2", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=57ebecf9-322b-4783-840d-96ad868348f2", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=y9G1R8BqJ_aMIVQKxuzcQyq5yDIt_nzolAeqLRGQm1tINb1afgKKcg", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "05e5a58f-d5ba-4169-a4a6-55abb20e9951", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=05e5a58f-d5ba-4169-a4a6-55abb20e9951", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=KP63YPqo1bjx-x_GuYlDisTJN9Op48ZL8aZKUku5ZZg8zjBbCFmO_A", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "92129923-151a-4486-9996-4d6247c147bb", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=92129923-151a-4486-9996-4d6247c147bb", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=e9DfM3hXF1tzLxfCBwRvfYKVF2WdPmOm9fMl5j0buQmnZJogC8GZAw", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "2395fc1c-d31f-4164-8b74-fb8da956bbd4", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=2395fc1c-d31f-4164-8b74-fb8da956bbd4", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=FMvEjhB-_f4SkQYJ9JLEo9K_Hc_CU0O5KCH_jSLGLOXvbKTT1qIa4w", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "840dc3f5-6c2d-4801-904a-59274ee7bde3", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=840dc3f5-6c2d-4801-904a-59274ee7bde3", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=Dzu4MXE0t4KfhozrVVBN00ENTcpPCmeMdshIWv9dmu-NcFtOfP_kUQ", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "650b6533-c14e-4c0b-bf5c-2eaa1df515e4", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=650b6533-c14e-4c0b-bf5c-2eaa1df515e4", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" }, { "@type": "ContactPoint", "@context": "http://schema.org", "@source": "TEE,52.0.0,20230814.08,40714d7904bcba6004af2a3472ff3bcc057e5c1e;en-US.url,52.0.0,2021.5.5.1,2021.5.5.1", "@entityExtractionTrustLevel": "Unknown", "@outputVersion": "1.0", "@schemaOrgVersion": "1.93", "url": "https://secure.fredhutch.org/site/R?i=SIHmP-Ex8b7mwY-ydziobbdY53Vk1BRvpB55QCieFNzJzrci4apRsg", "url/urlTextSpan": { "@type": "TextSpan", "beginIndex": 0, "length": 92 }, "@EntityId": "8750377b-a0a1-43d7-a57e-d7070570b516", "@correlationTrail": "AssetId=45a8e4bc-7938-4476-9e2d-49a2a32784ef;ExtractionId=d279ae8f-98de-4ab6-b8a0-32304ca50a00;EntityId=8750377b-a0a1-43d7-a57e-d7070570b516", "@extractionTimeUtc": "2023-08-24T00:02:17.4452329Z" } ]